These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 2948959)

  • 1. Inhibition of phospholipase A2 by "lipocortins" and calpactins. An effect of binding to substrate phospholipids.
    Davidson FF; Dennis EA; Powell M; Glenney JR
    J Biol Chem; 1987 Feb; 262(4):1698-705. PubMed ID: 2948959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of lipocortin I and an immunologically unrelated 33-kDa protein as epidermal growth factor receptor/kinase substrates and phospholipase A2 inhibitors.
    Haigler HT; Schlaepfer DD; Burgess WH
    J Biol Chem; 1987 May; 262(14):6921-30. PubMed ID: 3032981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipocortin-like anti-phospholipase A2 activity of endonexin.
    Fauvel J; Salles JP; Roques V; Chap H; Rochat H; Douste-Blazy L
    FEBS Lett; 1987 May; 216(1):45-50. PubMed ID: 2953628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of phospholipase A2 by protein I.
    Khanna NC; Hee-Chong M; Severson DL; Tokuda M; Chong SM; Waisman DM
    Biochem Biophys Res Commun; 1986 Sep; 139(2):455-60. PubMed ID: 2945554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipocortin inhibition of extracellular and intracellular phospholipases A2 is substrate concentration dependent.
    Aarsman AJ; Mynbeek G; van den Bosch H; Rothhut B; Prieur B; Comera C; Jordan L; Russo-Marie F
    FEBS Lett; 1987 Jul; 219(1):176-80. PubMed ID: 2954856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic peptide from lipocortin I has no phospholipase A2 inhibitory activity.
    van Binsbergen J; Slotboom AJ; Aarsman AJ; de Haas GH
    FEBS Lett; 1989 Apr; 247(2):293-7. PubMed ID: 2523817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibition of phospholipase A2 by different lipocortins.
    Weber G; Ferber E
    Biol Chem Hoppe Seyler; 1990 Aug; 371(8):725-31. PubMed ID: 2144971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding and inhibition studies on lipocortins using phosphatidylcholine vesicles and phospholipase A2 from snake venom, pancreas, and a macrophage-like cell line.
    Davidson FF; Lister MD; Dennis EA
    J Biol Chem; 1990 Apr; 265(10):5602-9. PubMed ID: 2138608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential anticoagulant activity of lipocortins and other calcium/phospholipid binding proteins.
    Chap H; Comfurius P; Bevers EM; Fauvel J; Vicendo P; Douste-Blazy L; Zwaal RF
    Biochem Biophys Res Commun; 1988 Feb; 150(3):972-8. PubMed ID: 2963637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium-independent phospholipases from guinea pig digestive tract as probes to study the mechanism of lipocortin.
    Gassama-Diagne A; Fauvel J; Chap H
    J Biol Chem; 1990 Mar; 265(8):4309-14. PubMed ID: 2137821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipocortin I and lipocortin II inhibit phosphoinositide- and polyphosphoinositide-specific phospholipase C. The effect results from interaction with the substrates.
    Machoczek K; Fischer M; Söling HD
    FEBS Lett; 1989 Jul; 251(1-2):207-12. PubMed ID: 2546821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies specific to a Ca2(+)-bound form of lipocortin I distinguish its Ca2(+)-dependent phospholipid-binding ability from its ability to inhibit phospholipase A2.
    Hayashi H; Owada MK; Sonobe S; Domae K; Yamanouchi T; Kakunaga T; Kitajima Y; Yaoita H
    Biochem J; 1990 Aug; 269(3):709-15. PubMed ID: 2143895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of two 67 kDa calcium-binding proteins from pig lung differing in affinity for phospholipids and in anti-phospholipase A2 activity.
    Fauvel J; Vicendo P; Roques V; Ragab-Thomas J; Granier C; Vilgrain I; Chambaz E; Rochat H; Chap H; Douste-Blazy L
    FEBS Lett; 1987 Sep; 221(2):397-402. PubMed ID: 2957233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sedimentation equilibrium analysis of five lipocortin-related phospholipase A2 inhibitors from human placenta. Evidence against a mechanistically relevant association between enzyme and inhibitor.
    Ahn NG; Teller DC; Bienkowski MJ; McMullen BA; Lipkin EW; de Haën C
    J Biol Chem; 1988 Dec; 263(35):18657-63. PubMed ID: 2974032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of phospholipase A2 inhibitory proteins in human mononuclear cells.
    Coméra C; Rothhut B; Russo-Marie F
    Eur J Biochem; 1990 Feb; 188(1):139-46. PubMed ID: 2138536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human skin phospholipase A2 by "lipocortins" is an indirect effect of substrate/lipocortin interaction.
    Bastian BC; Sellert C; Seekamp A; Römisch J; Pâques EP; Bröcker EB
    J Invest Dermatol; 1993 Sep; 101(3):359-63. PubMed ID: 8370974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phospholipase A2 inhibitory activity in thymocytes of dexamethasone-treated mice--possible implication of lipocortins.
    Errasfa M; Rothhut B; Russo-Marie F
    Biochem Biophys Res Commun; 1989 Feb; 159(1):53-60. PubMed ID: 2522304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biology of phospholipase inhibitory proteins.
    Hirata F; Hirata A
    Adv Exp Med Biol; 1990; 279():211-8. PubMed ID: 2151416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibitory effects of calphobindins on phospholipase A2 and phospholipase C].
    Utsumi T
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Jul; 44(7):793-9. PubMed ID: 1386868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of normal and psoriatic epidermal phospholipase A2 by picomolar concentrations of recombinant human lipocortin I.
    Cartwright PH; Ilderton E; Sowden JM; Yardley HJ
    Br J Dermatol; 1989 Aug; 121(2):155-60. PubMed ID: 2528367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.